Literature DB >> 18655231

Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination.

Mirko Arcuri1, Manuela Cappelletti, Immacolata Zampaglione, Luigi Aurisicchio, Alfredo Nicosia, Gennaro Ciliberto, Elena Fattori.   

Abstract

BACKGROUND: Gene electro-transfer (GET) increases DNA uptake and expression by muscle cells following intramuscular plasmid injection. This technology has been used to increase the production of therapeutic proteins, such as cytokines and growth factors, and to improve immunization efficiency following the injection of antigen-encoding plasmids.
METHODS: Hepatitis C virus (HCV) E2 and cytokine encoding plasmids were co-injected in the mouse quadriceps with or without GET and vaccination outcome was monitored by analysis of antigen-specific cellular-mediated or antibody-mediated immunity.
RESULTS: GET co-injection of cytokine-encoding and HCV E2-encoding plasmids strongly enhanced T- or B-cell responses to various levels, depending on the particular combination used.
CONCLUSIONS: We propose that a cocktail of plasmids followed by GET can be the most efficient and fine-tunable approach for genetic immunization. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655231     DOI: 10.1002/jgm.1217

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  3 in total

Review 1.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 2.  Immunopotentiating and Delivery Systems for HCV Vaccines.

Authors:  Alexander K Andrianov; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

3.  Immuno nanoparticles integrated electrical control of targeted cancer cell development using whole cell bioelectronic device.

Authors:  Evangelia Hondroulis; Rui Zhang; Chengxiao Zhang; Chunying Chen; Kosuke Ino; Tomokazu Matsue; Chen-Zhong Li
Journal:  Theranostics       Date:  2014-07-13       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.